Hederacolchiside A1 T2P2806
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Hederacolchiside A1 shows anti-leishmanial activity, it exhibits a strong antiproliferative activity on all stages of development of the parasite by altering membrane integrity and potential. Hederacolchiside A1 shows antiproliferation activities in three
CAS nr:
106577-39-3
Purity:
98%
Molecular Weight:
897,1
SMILES:
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@H](CO[C@H]2O[C@H]3CC[C@]4([C@H](C3(C)C)CC[C@@]5([C@@H]4CC=C6[C@]5(CC[C@@]7([C@H]6CC(CC7)(C)C)C(=O)O)C)C)C)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)O)O)O
Formula:
C47H76O16
Pathway:
PI3K/Akt/mTOR signaling,PI3K/Akt/mTOR signaling,MAPK,PI3K/Akt/mTOR signaling,Microbiology/Virology,Cytoskeletal Signaling,Apoptosis,MAPK
Target:
mTOR,PI3K,MEK,Akt,Parasite,Akt,Apoptosis,ERK
